None listed
Conditions
Interventions
Others : LBBAP group
- All pacemaker implantation should be performed in standard manner.
- A lead should be placed in the right atrial appendage or septum where acceptable sensing (P wave >1mV) and
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - >18 years old - Sinus node dysfunction with symptoms - Atrioventricular conduction delay (PR interval > 180ms)
Exclusion criteria
Exclusion criteria: - Subject was unable to provide written informed consent or participate in long-term follow-up. - Permanent atrial fibrillation - Persistent advanced atrioventricular conduction disturbance (Mobitz type II or 3rd degree) with >40% of expected ventricular pacing burden - Mechanical tricuspid valve - Ventricular septal defect or scar - Left ventricular ejection fraction < 35% who indicated cardiac resynchronization therapy - Previous heart transplantation - Pregnant and/or lactating women. - Life expectancy <2 year - Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| death;heart failure;new onset permanent atrial fibrillation | — |
Secondary
| Measure | Time frame |
|---|---|
| death rate;stroke;cardiac re-hospitalization;re-implant;atrial fibrillation;atrial fibrillation;atrial fibrillation;Procedure time;LBBAP success rate;LV ejection fraction;LV dimension;LA dimension;Valvular heart disease;E/e’ value;sensing value, pacing threshold, impedance | — |
Countries
Korea, Republic of
Contacts
Public ContactGiByoung Nam
Asan Medical Center
Outcome results
None listed